Earnings Call · Q4 FY2025·2026-03-04

Q4 25EPS +25.45%·Rev n/aQ3 25EPS +100.00%*·Rev n/aQ2 25EPS +100.00%*·Rev n/aQ1 25EPS +100.00%*·Rev n/a⚠ consensus missing

Niagen Bioscience, Inc. NAGE

Kendall Knysch — Investor Relations or Call Moderator

Robert Fried — Chief Executive Officer

Andrew Shao — Senior Vice President of Scientific and Regulatory Affairs

Ozan Pamir — Chief Financial Officer

+1.4%1d on move date+0.7% vs SPY3d+3.9%5d+7.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NAGE calls or request research access.

More NAGE calls Browse calls Request research access